Cargando…
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus
Status epilepticus that cannot be controlled with first- and second-line agents is called refractory status epilepticus (RSE), a condition that is associated with significant morbidity and mortality. Most experts agree that treatment of RSE necessitates the use of continuous infusion intravenous ane...
Autores principales: | Reznik, Michael E., Berger, Karen, Claassen, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882483/ https://www.ncbi.nlm.nih.gov/pubmed/27213459 http://dx.doi.org/10.3390/jcm5050054 |
Ejemplares similares
-
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
por: Madžar, Dominik, et al.
Publicado: (2018) -
Volatile Anesthetic for Management of Super-refractory Status Epilepticus
por: Tomar, Gaurav Singh, et al.
Publicado: (2017) -
The Roles of Glutamate Receptors and Their Antagonists in Status Epilepticus, Refractory Status Epilepticus, and Super-Refractory Status Epilepticus
por: Huang, Tzu-Hsin, et al.
Publicado: (2023) -
Refractory and Super-refractory Status Epilepticus
por: Samanta, Debopam, et al.
Publicado: (2020) -
Review and Updates on the Treatment of Refractory and Super Refractory Status Epilepticus
por: Alolayan, Yazeed S., et al.
Publicado: (2021)